Home › Funds › Two Sigma Investments › IBRX
Two Sigma Investments position in IBRX
IMMUNITYBIO INC · Health Care
Latest position (Q2 2026)11.10M sh
Reported value held$97.16M
Portfolio Weight0.08%
First reportedQ4 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 28.32K | $72.49K | New |
| Q1 2025 | 23.80K | $71.64K | Reduce |
| Q2 2025 | 802.56K | $2.12M | Add |
| Q3 2025 | 2.61M | $6.42M | Add |
| Q4 2025 | 4.72M | $9.34M | Add |
| Q1 2026 | 4.39M | $33.64M | Reduce |
| Q2 2026 | 11.10M | $97.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IBRX
- BlackRock Inc 34.08M sh · $298.40M · Q2 2026
- D. E. Shaw & Co 11.55M sh · $101.13M · Q2 2026
- Geode Capital Management 9.85M sh · $86.23M · Q2 2026
- Vanguard Group 32.78M sh · $64.90M · Q4 2025
- Citadel Advisors 5.67M sh · $49.68M · Q2 2026
- Millennium Management 5.58M sh · $48.85M · Q2 2026
- Northern Trust Corp 3.57M sh · $31.21M · Q2 2026
- Morgan Stanley 3.43M sh · $30.05M · Q2 2026
- Goldman Sachs Group 3.23M sh · $28.32M · Q2 2026
- UBS Group AG 3.20M sh · $27.98M · Q2 2026
- Charles Schwab Investment Management 2.89M sh · $25.29M · Q2 2026